Risk Factors Associated With Clostridium difficile-Associated Diarrhea

被引:4
|
作者
Gupta, Aarzoo [1 ]
Savanti, F. N. U. [2 ]
Singh, Balvender [3 ]
Sachdev, Priyanka [4 ]
Raj, Deepak [4 ]
Garg, Ishan [5 ]
Aruwani, Suraj K. [6 ]
Shaukat, Faizan [7 ]
机构
[1] Safdarjang Hosp, Internal Med, Faridabad, India
[2] Liaquat Natl Hosp & Med Coll, Internal Med, Karachi, Pakistan
[3] Ghulam Mohammad Mahar Med Coll, Internal Med, Sukkur, Pakistan
[4] Liaquat Univ Med & Hlth Sci, Internal Med, Jamshoro, Pakistan
[5] Ross Univ, Internal Med, Sch Med, Miami, FL USA
[6] Jinnah Sindh Med Univ, Internal Med, Karachi, Pakistan
[7] Dow Univ Hlth Sci, Internal Med, Karachi, Pakistan
关键词
clostridium difficile; diarrhea; gastrointestinal symptoms; cdi; spore forming bacilli; EPIDEMIOLOGY; INFECTION; OBESITY; ACQUISITION;
D O I
10.7759/cureus.18115
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Recent years have been alarming due to the sudden, dramatic rise in the incidence of Clostridium difficile infection ( CDI). Identifying and addressing the risk factors associated with CDI will help in reducing the incidence of infection and associated complications. Methods: This case-control study was conducted in a tertiary care hospital in Pakistan from June 2020 to March 2021, in which 200 patients diagnosed with Clostridium difficile-associated diarrhea (CDAD) were enrolled in the study. CDAD was diagnosed based on clinical symptoms and stool enzyme immunoassay. Another 200 participants without a diagnosis of CDAD were enrolled from the outpatient department as a control group. Participants were enrolled after seeking informed consent. Results: In patients older than 65, risk of CDI was higher compared to participants lower than 65 years old (15.5% vs. 8.0%; p value: 0.02). Hospitalization (25.5% vs. 6.0%; p value < 0.0001), the use of proton pump inhibitors in last 30 days (23.0% vs. 10.5%; p value: 0.001), and use of antibiotics in the last 30 days (36.0% vs. 10.5%; p value < 0.0001) were significantly higher in participants with CDI. Conclusion: Hospitalization, the usage of proton pump inhibitors, and antibiotics in the last 30 days were significantly associated with CDI. A higher incidence of CDI was associated with risk factors like increased body mass index, diabetes, chronic kidney disease, and malignancy.
引用
收藏
页数:4
相关论文
共 50 条
  • [21] Risk factors for Clostridium difficile-associated diarrhea in Taiwanese hospitalized patients.
    Chen, Ying-Chun
    Su, Yu-Ting
    Chou, Hsiang-Lin
    Shen, Yi-Feng
    Chien, Yu-Yuan
    Chi-LienHsiao
    [J]. PHARMACOTHERAPY, 2017, 37 (06): : E49 - E50
  • [22] QUINOLONES A nosocomial risk factor for Clostridium difficile-associated diarrhea
    Bhalla, Alka
    [J]. CANADIAN PHARMACISTS JOURNAL, 2006, 139 (02) : 47 - 49
  • [23] Clostridium difficile-associated diarrhea in dialysis patients
    Oh, Sook Eui
    Lee, Seung Min
    Lee, Young-Ki
    Choi, Sun Ryoung
    Choi, Myung-Jin
    Kim, Jwa-Kyung
    Song, Young Rim
    Kim, Soo Jin
    Park, Tae Jin
    Kim, Sung Gyun
    Oh, Jieun
    Suh, Jang Won
    Yoon, Jong -Woo
    Koo, Ja-Ryong
    Kim, Hyung Jik
    Noh, Jung Woo
    [J]. KIDNEY RESEARCH AND CLINICAL PRACTICE, 2013, 32 (01) : 27 - 31
  • [24] Fluoroquinolone use and Clostridium difficile-associated diarrhea
    McCusker, ME
    Harris, AD
    Perencevich, E
    Roghmann, MC
    [J]. EMERGING INFECTIOUS DISEASES, 2003, 9 (06) : 730 - 733
  • [25] Clostridium difficile-associated diarrhea in a pediatric hospital
    Spivack, JG
    Eppes, SC
    Klein, JD
    [J]. CLINICAL PEDIATRICS, 2003, 42 (04) : 347 - 352
  • [26] Clostridium difficile-Associated Diarrhea in the Oncology Patient
    Neemann, Kari
    Freifeld, Alison
    [J]. JOURNAL OF ONCOLOGY PRACTICE, 2017, 13 (01) : 25 - +
  • [27] Bezlotoxumab for the treatment of Clostridium difficile-associated diarrhea
    Thakare, R.
    Dasgupta, A.
    Chopra, S.
    [J]. DRUGS OF TODAY, 2017, 53 (07) : 385 - 392
  • [28] Diagnosis of Clostridium difficile-associated diarrhea and odor
    Wilcox, Mark H.
    [J]. CLINICAL INFECTIOUS DISEASES, 2007, 45 (08) : 1110 - 1110
  • [29] Management of Severe Clostridium difficile-Associated Diarrhea
    Michael J. Krier
    George Triadafilopoulos
    [J]. Digestive Diseases and Sciences, 2009, 54 : 1199 - 1202
  • [30] Clostridium difficile-associated diarrhea in infants and children
    Vuletic, Biljana
    Ristanovic, Elizabeta
    Markovic, Slavica
    Raskovic, Zorica
    Radlovic, Vladimir
    Igrutinovic, Zoran
    [J]. SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2017, 145 (1-2) : 85 - 88